Optimum level of combined adrenergic blockade for the experimental study of hemorrhagic shock.
D000136:Acid-Base Equilibrium; D000138:Acidosis; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000704:Analysis of Variance; D000818:Animals; D001158:Arteries; D001769:Blood; D001810:Blood Volume; D006863:Hydrogen-Ion Concentration; D010643:Phenoxybenzamine / Q000494:pharmacology*; D011817:Rabbits; D012771:Shock, Hemorrhagic / Q000097:blood* / Q000378:metabolism; D013565:Sympatholytics / Q000494:pharmacology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D010643:Phenoxybenzamine